鹿児島赤十字病院は、鹿児島県鹿児島市平川町に所在する日本赤十字社の医療機関である。設立当時のサナトリウムとしての立地選定から、2004年の合併前の鹿児島市の南端近くに位置する。 リウマチ膠原病に重点を置いた人員設備を備えている。

During the past decade, Kagoshima Red Cross Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kagoshima Red Cross Hospital" are "Ankylosing Spondylitis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Kagoshima Red Cross Hospital" in a lesser frequency.

Most popular intervention types in "Kagoshima Red Cross Hospital" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kagoshima Red Cross Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kagoshima Red Cross Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kagoshima Red Cross Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kagoshima Red Cross Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".